In chronic myeloid leukemia, it has been observed that cellular proliferation is promoted via induction of phosphatidylinositol 3-kinase (PI3K)/protein kinase B (AKT) and MAPK pathways [127]. Here, AKT1 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.